Metformin (generic) or Glucophage (brand) has become a very popular therapeutic agent in multiple medical conditions. According to David McCulloch (UpToDate 19.3- January, 2012) two classes of oral hypoglycemic medications directly improve insulin action: biguanides (metformin) and thiazolodinediones. Metformin is widely considered to be the first... Read more
I have been on service at Children's National Medical Center this past week. This means I am the physician that admits children and adolescents with new onset diabetes. As we are a tertiary children's hospital, many of our children are referred from great distances to both confirm the diagnosis and then treat accordingly. It is extremely important... Read more
In 1983, Prochaska et. al published "Stages and Processes of Self-Change of Smoking: Toward an Integrative Model of Change" in the Journal of Consulting and Clinical Psychology, Volume 51, No. 3, 390-395. Although the paper targeted smoking cessation, this change model has been applied and is appropriate in many clinical situations. The ability to... Read more
The technology revolution in diabetes gadgetry continues to blossom. We will address some latest devices and add a cautionary note about the report of a glitch in one of the insulin pumps (source -Diabetes in control.com.)
mySentry Remote Glucose monitor (FDA approved) works in tandem with the Medtronic Minimed Paradigm Real-Time Revel... Read more
It is always appropriate to provide good news; but even more exciting when a study continues to "keep on giving." The 1993 Diabetes Control and Complications Trial (DCCT), which is likely the most quoted trial in the history of scholarly diabetes, continues to provide further promising news in regard to diabetes microvascular... Read more
